RIO DE JANEIRO, BRAZIL - An Argentine laboratory will start human trials of a serum made from plasma of horses infected with the Sars-Cov-2 coronavirus for the treatment of Covid-19. On Friday, July 24th, the Argentine health regulatory agency approved the research's human clinical trials stage.
The National Administration of Medicines, Food and Medical Technology (ANMAT) approved the clinical protocol of the hyperimmune serum against Covid-19. The drug is considered a potential treatment for coronavirus infection.
There is no approved treatment or vaccine for Covid-19 to date. Human trials will assess the safety and efficacy . . .